ID   TRIB3_HUMAN             Reviewed;         358 AA.
AC   Q96RU7; Q53GU4; Q53ZW7; Q6I9Y9; Q8TAI6; Q9H5M8; Q9NUD2;
DT   01-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2003, sequence version 2.
DT   12-OCT-2022, entry version 190.
DE   RecName: Full=Tribbles homolog 3;
DE            Short=TRB-3;
DE   AltName: Full=Neuronal cell death-inducible putative kinase;
DE   AltName: Full=SINK;
DE   AltName: Full=p65-interacting inhibitor of NF-kappa-B;
GN   Name=TRIB3; Synonyms=C20orf97, NIPK, SKIP3, TRB3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, INDUCTION, AND INTERACTION
RP   WITH ATF4.
RX   PubMed=12743605; DOI=10.1038/sj.onc.1206367;
RA   Bowers A.J., Scully S., Boylan J.F.;
RT   "SKIP3, a novel Drosophila tribbles ortholog, is overexpressed in human
RT   tumors and is regulated by hypoxia.";
RL   Oncogene 22:2823-2835(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, INDUCTION, AND
RP   INTERACTION WITH RELA.
RX   PubMed=12736262; DOI=10.1074/jbc.m209814200;
RA   Wu M., Xu L.G., Zhai Z., Shu H.B.;
RT   "SINK is a p65-interacting negative regulator of NF-kappaB-dependent
RT   transcription.";
RL   J. Biol. Chem. 278:27072-27079(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND INTERACTION
RP   WITH MAP2K1 AND MAP2K7.
RX   PubMed=15299019; DOI=10.1074/jbc.m407732200;
RA   Kiss-Toth E., Bagstaff S.M., Sung H.Y., Jozsa V., Dempsey C., Caunt J.C.,
RA   Oxley K.M., Wyllie D.H., Polgar T., Harte M., O'Neill L.A.J.,
RA   Qwarnstrom E.E., Dower S.K.;
RT   "Human tribbles, a protein family controlling mitogen-activated protein
RT   kinase cascades.";
RL   J. Biol. Chem. 279:42703-42708(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=15781252; DOI=10.1016/j.bbrc.2005.02.149;
RA   Ord D., Ord T.;
RT   "Characterization of human NIPK (TRB3, SKIP3) gene activation in stressful
RT   conditions.";
RL   Biochem. Biophys. Res. Commun. 330:210-218(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Shan Y.X., Yu L.;
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-84.
RC   TISSUE=Cervix, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   FUNCTION, INDUCTION, AND INTERACTION WITH DDIT3.
RX   PubMed=15775988; DOI=10.1038/sj.emboj.7600596;
RA   Ohoka N., Yoshii S., Hattori T., Onozaki K., Hayashi H.;
RT   "TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway
RT   and is involved in cell death.";
RL   EMBO J. 24:1243-1255(2005).
RN   [12]
RP   INDUCTION.
RX   PubMed=16129579; DOI=10.1016/j.cellsig.2005.08.002;
RA   Schwarzer R., Dames S., Tondera D., Klippel A., Kaufmann J.;
RT   "TRB3 is a PI 3-kinase dependent indicator for nutrient starvation.";
RL   Cell. Signal. 18:899-909(2006).
RN   [13]
RP   INTERACTION WITH DDIT3.
RX   PubMed=17872950; DOI=10.1074/jbc.m703735200;
RA   Ohoka N., Hattori T., Kitagawa M., Onozaki K., Hayashi H.;
RT   "Critical and functional regulation of CHOP (C/EBP homologous protein)
RT   through the N-terminal portion.";
RL   J. Biol. Chem. 282:35687-35694(2007).
RN   [14]
RP   FUNCTION, INTERACTION WITH APOBEC3A AND APOBEC3C, AND SUBCELLULAR LOCATION.
RX   PubMed=22977230; DOI=10.1074/jbc.m112.372722;
RA   Aynaud M.M., Suspene R., Vidalain P.O., Mussil B., Guetard D., Tangy F.,
RA   Wain-Hobson S., Vartanian J.P.;
RT   "Human Tribbles 3 protects nuclear DNA from cytidine deamination by
RT   APOBEC3A.";
RL   J. Biol. Chem. 287:39182-39192(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-60; ARG-84; HIS-153; HIS-274 AND
RP   LYS-347.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Inactive protein kinase which acts as a regulator of the
CC       integrated stress response (ISR), a process for adaptation to various
CC       stress (PubMed:15781252, PubMed:15775988). Inhibits the transcriptional
CC       activity of DDIT3/CHOP and is involved in DDIT3/CHOP-dependent cell
CC       death during ER stress (PubMed:15781252, PubMed:15775988). May play a
CC       role in programmed neuronal cell death but does not appear to affect
CC       non-neuronal cells (PubMed:15781252, PubMed:15775988). Acts as a
CC       negative feedback regulator of the ATF4-dependent transcription during
CC       the ISR: while TRIB3 expression is promoted by ATF4, TRIB3 protein
CC       interacts with ATF4 and inhibits ATF4 transcription activity (By
CC       similarity). Disrupts insulin signaling by binding directly to Akt
CC       kinases and blocking their activation (By similarity). May bind
CC       directly to and mask the 'Thr-308' phosphorylation site in AKT1 (By
CC       similarity). Interacts with the NF-kappa-B transactivator p65 RELA and
CC       inhibits its phosphorylation and thus its transcriptional activation
CC       activity (PubMed:12736262). Interacts with MAPK kinases and regulates
CC       activation of MAP kinases (PubMed:15299019). Can inhibit APOBEC3A
CC       editing of nuclear DNA (PubMed:22977230).
CC       {ECO:0000250|UniProtKB:Q8K4K2, ECO:0000269|PubMed:12736262,
CC       ECO:0000269|PubMed:15299019, ECO:0000269|PubMed:15775988,
CC       ECO:0000269|PubMed:15781252, ECO:0000269|PubMed:22977230}.
CC   -!- SUBUNIT: Interacts with AKT1, AKT2, MAP2K1 and MAP2K7
CC       (PubMed:15299019). Interacts with ATF4 (PubMed:12743605). Interacts
CC       with DDIT3/CHOP and inhibits its interaction with EP300/P300
CC       (PubMed:15775988, PubMed:17872950). Interacts with APOBEC3C
CC       (PubMed:22977230). Interacts (via N-terminus) with APOBEC3A
CC       (PubMed:22977230). Interacts with RELA (PubMed:12736262).
CC       {ECO:0000269|PubMed:12736262, ECO:0000269|PubMed:12743605,
CC       ECO:0000269|PubMed:15299019, ECO:0000269|PubMed:15775988,
CC       ECO:0000269|PubMed:17872950, ECO:0000269|PubMed:22977230}.
CC   -!- INTERACTION:
CC       Q96RU7; Q9ULX6: AKAP8L; NbExp=3; IntAct=EBI-492476, EBI-357530;
CC       Q96RU7; Q9NRW3: APOBEC3C; NbExp=5; IntAct=EBI-492476, EBI-1044593;
CC       Q96RU7; Q9H6L4: ARMC7; NbExp=3; IntAct=EBI-492476, EBI-742909;
CC       Q96RU7; P18848: ATF4; NbExp=16; IntAct=EBI-492476, EBI-492498;
CC       Q96RU7; O95817: BAG3; NbExp=3; IntAct=EBI-492476, EBI-747185;
CC       Q96RU7; P41182: BCL6; NbExp=4; IntAct=EBI-492476, EBI-765407;
CC       Q96RU7; Q13515: BFSP2; NbExp=3; IntAct=EBI-492476, EBI-10229433;
CC       Q96RU7; Q0VAL7: C21orf58; NbExp=3; IntAct=EBI-492476, EBI-10226774;
CC       Q96RU7; Q6P5X5: C22orf39; NbExp=3; IntAct=EBI-492476, EBI-7317823;
CC       Q96RU7; Q9HC52: CBX8; NbExp=3; IntAct=EBI-492476, EBI-712912;
CC       Q96RU7; Q13111: CHAF1A; NbExp=5; IntAct=EBI-492476, EBI-1020839;
CC       Q96RU7; P51800-3: CLCNKA; NbExp=3; IntAct=EBI-492476, EBI-11980535;
CC       Q96RU7; P78358: CTAG1B; NbExp=3; IntAct=EBI-492476, EBI-1188472;
CC       Q96RU7; G5E9A7: DMWD; NbExp=3; IntAct=EBI-492476, EBI-10976677;
CC       Q96RU7; Q6W0C5: DPPA3; NbExp=3; IntAct=EBI-492476, EBI-12082590;
CC       Q96RU7; Q86UW9: DTX2; NbExp=3; IntAct=EBI-492476, EBI-740376;
CC       Q96RU7; O95967: EFEMP2; NbExp=3; IntAct=EBI-492476, EBI-743414;
CC       Q96RU7; O15197-2: EPHB6; NbExp=3; IntAct=EBI-492476, EBI-10182490;
CC       Q96RU7; Q9NQT4: EXOSC5; NbExp=3; IntAct=EBI-492476, EBI-371876;
CC       Q96RU7; Q6NZ36-4: FAAP20; NbExp=3; IntAct=EBI-492476, EBI-12013806;
CC       Q96RU7; Q3B820: FAM161A; NbExp=3; IntAct=EBI-492476, EBI-719941;
CC       Q96RU7; Q86YD7: FAM90A1; NbExp=3; IntAct=EBI-492476, EBI-6658203;
CC       Q96RU7; Q8NEA6-2: GLIS3; NbExp=3; IntAct=EBI-492476, EBI-12232117;
CC       Q96RU7; Q9NWQ4-1: GPATCH2L; NbExp=3; IntAct=EBI-492476, EBI-11959863;
CC       Q96RU7; P62993: GRB2; NbExp=3; IntAct=EBI-492476, EBI-401755;
CC       Q96RU7; O14929: HAT1; NbExp=3; IntAct=EBI-492476, EBI-2339359;
CC       Q96RU7; P56524-2: HDAC4; NbExp=3; IntAct=EBI-492476, EBI-11953488;
CC       Q96RU7; P52597: HNRNPF; NbExp=3; IntAct=EBI-492476, EBI-352986;
CC       Q96RU7; P09067: HOXB5; NbExp=3; IntAct=EBI-492476, EBI-3893317;
CC       Q96RU7; P31273: HOXC8; NbExp=3; IntAct=EBI-492476, EBI-1752118;
CC       Q96RU7; Q14005-2: IL16; NbExp=3; IntAct=EBI-492476, EBI-17178971;
CC       Q96RU7; Q0VD86: INCA1; NbExp=3; IntAct=EBI-492476, EBI-6509505;
CC       Q96RU7; Q9C086: INO80B; NbExp=3; IntAct=EBI-492476, EBI-715611;
CC       Q96RU7; P78412: IRX6; NbExp=3; IntAct=EBI-492476, EBI-12100506;
CC       Q96RU7; Q63ZY3: KANK2; NbExp=5; IntAct=EBI-492476, EBI-2556193;
CC       Q96RU7; Q2WGJ6: KLHL38; NbExp=3; IntAct=EBI-492476, EBI-6426443;
CC       Q96RU7; Q7Z3Y9: KRT26; NbExp=3; IntAct=EBI-492476, EBI-12084444;
CC       Q96RU7; Q96BZ8: LENG1; NbExp=3; IntAct=EBI-492476, EBI-726510;
CC       Q96RU7; P25791-3: LMO2; NbExp=3; IntAct=EBI-492476, EBI-11959475;
CC       Q96RU7; Q8TAP4-4: LMO3; NbExp=3; IntAct=EBI-492476, EBI-11742507;
CC       Q96RU7; Q99750: MDFI; NbExp=3; IntAct=EBI-492476, EBI-724076;
CC       Q96RU7; Q8IVT2: MISP; NbExp=3; IntAct=EBI-492476, EBI-2555085;
CC       Q96RU7; O43482: OIP5; NbExp=3; IntAct=EBI-492476, EBI-536879;
CC       Q96RU7; Q9UM07: PADI4; NbExp=3; IntAct=EBI-492476, EBI-1042511;
CC       Q96RU7; Q9BYG5: PARD6B; NbExp=3; IntAct=EBI-492476, EBI-295391;
CC       Q96RU7; Q92824-2: PCSK5; NbExp=3; IntAct=EBI-492476, EBI-11956269;
CC       Q96RU7; Q99697-2: PITX2; NbExp=3; IntAct=EBI-492476, EBI-12138495;
CC       Q96RU7; Q96KN3: PKNOX2; NbExp=3; IntAct=EBI-492476, EBI-2692890;
CC       Q96RU7; Q5T8A7: PPP1R26; NbExp=3; IntAct=EBI-492476, EBI-308500;
CC       Q96RU7; Q7Z5V6-2: PPP1R32; NbExp=3; IntAct=EBI-492476, EBI-12000762;
CC       Q96RU7; O43741: PRKAB2; NbExp=3; IntAct=EBI-492476, EBI-1053424;
CC       Q96RU7; O14744: PRMT5; NbExp=2; IntAct=EBI-492476, EBI-351098;
CC       Q96RU7; A6NJB7-2: PRR19; NbExp=3; IntAct=EBI-492476, EBI-11998870;
CC       Q96RU7; Q96KN7: RPGRIP1; NbExp=3; IntAct=EBI-492476, EBI-1050213;
CC       Q96RU7; Q96KN7-4: RPGRIP1; NbExp=3; IntAct=EBI-492476, EBI-11525164;
CC       Q96RU7; Q96NU1: SAMD11; NbExp=3; IntAct=EBI-492476, EBI-14067109;
CC       Q96RU7; Q8IYX7: SAXO1; NbExp=3; IntAct=EBI-492476, EBI-3957636;
CC       Q96RU7; Q9BWG6: SCNM1; NbExp=3; IntAct=EBI-492476, EBI-748391;
CC       Q96RU7; Q9NUL5-4: SHFL; NbExp=3; IntAct=EBI-492476, EBI-11955083;
CC       Q96RU7; P09234: SNRPC; NbExp=3; IntAct=EBI-492476, EBI-766589;
CC       Q96RU7; Q99932-2: SPAG8; NbExp=3; IntAct=EBI-492476, EBI-11959123;
CC       Q96RU7; Q9NZD8: SPG21; NbExp=3; IntAct=EBI-492476, EBI-742688;
CC       Q96RU7; Q7Z699: SPRED1; NbExp=4; IntAct=EBI-492476, EBI-5235340;
CC       Q96RU7; P51687: SUOX; NbExp=3; IntAct=EBI-492476, EBI-3921347;
CC       Q96RU7; Q9Y242: TCF19; NbExp=3; IntAct=EBI-492476, EBI-7413767;
CC       Q96RU7; Q9BXF9: TEKT3; NbExp=3; IntAct=EBI-492476, EBI-8644516;
CC       Q96RU7; Q8WW24: TEKT4; NbExp=5; IntAct=EBI-492476, EBI-750487;
CC       Q96RU7; Q08117-2: TLE5; NbExp=3; IntAct=EBI-492476, EBI-11741437;
CC       Q96RU7; Q5W5X9-3: TTC23; NbExp=3; IntAct=EBI-492476, EBI-9090990;
CC       Q96RU7; Q8WUN7: UBTD2; NbExp=3; IntAct=EBI-492476, EBI-12867288;
CC       Q96RU7; A0A024R8A9: USP20; NbExp=3; IntAct=EBI-492476, EBI-14096082;
CC       Q96RU7; Q9BRU9: UTP23; NbExp=3; IntAct=EBI-492476, EBI-5457544;
CC       Q96RU7; Q8TAU3: ZNF417; NbExp=3; IntAct=EBI-492476, EBI-740727;
CC       Q96RU7; Q96SQ5: ZNF587; NbExp=3; IntAct=EBI-492476, EBI-6427977;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22977230}.
CC   -!- TISSUE SPECIFICITY: Highest expression in liver, pancreas, peripheral
CC       blood leukocytes and bone marrow. Also highly expressed in a number of
CC       primary lung, colon and breast tumors. Expressed in spleen, thymus, and
CC       prostate and is undetectable in other examined tissues, including
CC       testis, ovary, small intestine, colon, leukocyte, heart, brain,
CC       placenta, lung, skeletal muscle, and kidney.
CC       {ECO:0000269|PubMed:12736262, ECO:0000269|PubMed:12743605,
CC       ECO:0000269|PubMed:15299019}.
CC   -!- INDUCTION: By hypoxia, TNF, and by nutrient starvation. Expression is
CC       PI 3-kinase and/or NF-kappa-B-dependent. Induced by ER stress via ATF4-
CC       DDIT3/CHOP pathway and can down-regulate its own induction by
CC       repression of ATF4-DDIT3/CHOP functions. {ECO:0000269|PubMed:12736262,
CC       ECO:0000269|PubMed:12743605, ECO:0000269|PubMed:15775988,
CC       ECO:0000269|PubMed:16129579}.
CC   -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC       inactive.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. Tribbles subfamily. {ECO:0000305}.
CC   -!- CAUTION: The role of this protein in Akt activation has been
CC       demonstrated by Du et al (PubMed:12791994) for the mouse ortholog but
CC       Iynedjian (PubMed:15469416) has not been able to reproduce the result
CC       in rat hepatocytes. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF250311; AAK58175.1; -; mRNA.
DR   EMBL; AJ697936; CAG27047.1; -; mRNA.
DR   EMBL; AY247738; AAP04407.1; -; mRNA.
DR   EMBL; AK026945; BAB15597.1; -; mRNA.
DR   EMBL; CR457366; CAG33647.1; -; mRNA.
DR   EMBL; AK222837; BAD96557.1; -; mRNA.
DR   EMBL; AL034548; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC019363; AAH19363.1; -; mRNA.
DR   EMBL; BC027484; AAH27484.1; -; mRNA.
DR   CCDS; CCDS12997.1; -.
DR   RefSeq; NP_001288117.1; NM_001301188.1.
DR   RefSeq; NP_001288119.1; NM_001301190.1.
DR   RefSeq; NP_001288122.1; NM_001301193.1.
DR   RefSeq; NP_001288125.1; NM_001301196.1.
DR   RefSeq; NP_001288130.1; NM_001301201.1.
DR   RefSeq; NP_066981.2; NM_021158.4.
DR   AlphaFoldDB; Q96RU7; -.
DR   SMR; Q96RU7; -.
DR   BioGRID; 121756; 136.
DR   CORUM; Q96RU7; -.
DR   IntAct; Q96RU7; 102.
DR   MINT; Q96RU7; -.
DR   STRING; 9606.ENSP00000217233; -.
DR   GlyGen; Q96RU7; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q96RU7; -.
DR   PhosphoSitePlus; Q96RU7; -.
DR   BioMuta; TRIB3; -.
DR   DMDM; 28201830; -.
DR   EPD; Q96RU7; -.
DR   jPOST; Q96RU7; -.
DR   MassIVE; Q96RU7; -.
DR   MaxQB; Q96RU7; -.
DR   PaxDb; Q96RU7; -.
DR   PeptideAtlas; Q96RU7; -.
DR   PRIDE; Q96RU7; -.
DR   ProteomicsDB; 78040; -.
DR   Antibodypedia; 6154; 593 antibodies from 33 providers.
DR   DNASU; 57761; -.
DR   Ensembl; ENST00000217233.9; ENSP00000217233.3; ENSG00000101255.12.
DR   GeneID; 57761; -.
DR   KEGG; hsa:57761; -.
DR   MANE-Select; ENST00000217233.9; ENSP00000217233.3; NM_021158.5; NP_066981.2.
DR   UCSC; uc002wdm.4; human.
DR   CTD; 57761; -.
DR   DisGeNET; 57761; -.
DR   GeneCards; TRIB3; -.
DR   HGNC; HGNC:16228; TRIB3.
DR   HPA; ENSG00000101255; Tissue enhanced (liver).
DR   MIM; 607898; gene.
DR   neXtProt; NX_Q96RU7; -.
DR   OpenTargets; ENSG00000101255; -.
DR   PharmGKB; PA25804; -.
DR   VEuPathDB; HostDB:ENSG00000101255; -.
DR   eggNOG; KOG0583; Eukaryota.
DR   GeneTree; ENSGT00950000182986; -.
DR   InParanoid; Q96RU7; -.
DR   PhylomeDB; Q96RU7; -.
DR   TreeFam; TF329785; -.
DR   PathwayCommons; Q96RU7; -.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-165158; Activation of AKT2.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-199418; Negative regulation of the PI3K/AKT network.
DR   Reactome; R-HSA-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-9633012; Response of EIF2AK4 (GCN2) to amino acid deficiency.
DR   Reactome; R-HSA-9648895; Response of EIF2AK1 (HRI) to heme deficiency.
DR   SignaLink; Q96RU7; -.
DR   SIGNOR; Q96RU7; -.
DR   BioGRID-ORCS; 57761; 10 hits in 1112 CRISPR screens.
DR   ChiTaRS; TRIB3; human.
DR   GeneWiki; TRIB3; -.
DR   GenomeRNAi; 57761; -.
DR   Pharos; Q96RU7; Tbio.
DR   PRO; PR:Q96RU7; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q96RU7; protein.
DR   Bgee; ENSG00000101255; Expressed in right lobe of liver and 127 other tissues.
DR   ExpressionAtlas; Q96RU7; baseline and differential.
DR   Genevisible; Q96RU7; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0031434; F:mitogen-activated protein kinase kinase binding; IBA:GO_Central.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004860; F:protein kinase inhibitor activity; IEA:UniProtKB-KW.
DR   GO; GO:0003714; F:transcription corepressor activity; ISS:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISS:BHF-UCL.
DR   GO; GO:0055106; F:ubiquitin-protein transferase regulator activity; ISS:BHF-UCL.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISS:BHF-UCL.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IMP:UniProtKB.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0045717; P:negative regulation of fatty acid biosynthetic process; ISS:BHF-UCL.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IDA:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0032092; P:positive regulation of protein binding; ISS:BHF-UCL.
DR   GO; GO:0051443; P:positive regulation of ubiquitin-protein transferase activity; ISS:BHF-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR   GO; GO:0010506; P:regulation of autophagy; ISS:UniProtKB.
DR   GO; GO:0010827; P:regulation of glucose transmembrane transport; ISS:BHF-UCL.
DR   GO; GO:0043405; P:regulation of MAP kinase activity; IDA:UniProtKB.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR024104; Tribbles/Ser_Thr_kinase_40.
DR   InterPro; IPR024106; Tribbles_TRB3.
DR   PANTHER; PTHR22961; PTHR22961; 1.
DR   PANTHER; PTHR22961:SF14; PTHR22961:SF14; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; Nucleus; Phosphoprotein; Protein kinase inhibitor;
KW   Reference proteome; Stress response; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..358
FT                   /note="Tribbles homolog 3"
FT                   /id="PRO_0000131866"
FT   DOMAIN          68..316
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..127
FT                   /note="Interaction with DDIT3/CHOP"
FT   REGION          1..54
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        15..35
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         12
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VARIANT         60
FT                   /note="T -> I (in a glioblastoma multiforme sample; somatic
FT                   mutation; dbSNP:rs757496714)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042372"
FT   VARIANT         84
FT                   /note="Q -> R (in dbSNP:rs2295490)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:17344846"
FT                   /id="VAR_023965"
FT   VARIANT         153
FT                   /note="R -> H (in dbSNP:rs35051116)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042373"
FT   VARIANT         274
FT                   /note="R -> H (in dbSNP:rs56291463)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042374"
FT   VARIANT         347
FT                   /note="E -> K (in dbSNP:rs56342286)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042375"
FT   CONFLICT        24
FT                   /note="N -> D (in Ref. 7; CAG33647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        105
FT                   /note="L -> P (in Ref. 6; BAB15597 and 8; BAD96557)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        114
FT                   /note="L -> V (in Ref. 3; AAK58175)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        194..195
FT                   /note="ER -> DREK (in Ref. 3; AAK58175)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   358 AA;  39578 MW;  CE15FD89A81E8D63 CRC64;
     MRATPLAAPA GSLSRKKRLE LDDNLDTERP VQKRARSGPQ PRLPPCLLPL SPPTAPDRAT
     AVATASRLGP YVLLEPEEGG RAYQALHCPT GTEYTCKVYP VQEALAVLEP YARLPPHKHV
     ARPTEVLAGT QLLYAFFTRT HGDMHSLVRS RHRIPEPEAA VLFRQMATAL AHCHQHGLVL
     RDLKLCRFVF ADRERKKLVL ENLEDSCVLT GPDDSLWDKH ACPAYVGPEI LSSRASYSGK
     AADVWSLGVA LFTMLAGHYP FQDSEPVLLF GKIRRGAYAL PAGLSAPARC LVRCLLRREP
     AERLTATGIL LHPWLRQDPM PLAPTRSHLW EAAQVVPDGL GLDEAREEEG DREVVLYG
//
